by Rebeca Ridings Figueroa | May 8, 2024 | Research
Cure CLCN4 Grant Awardees Announced – Summaries For Families We are pleased to announce the recipients of our recent pilot grant call, awarding a total of £150,000 to advance the understanding of CLCN4-related condition. We received a number of strong proposals,...
by Rebeca Ridings Figueroa | May 7, 2024 | Research
Cure CLCN4 Pilot Grant Program: Meet the Recipients We are pleased to announce the recipients of our recent pilot grant call, awarding a total of £150,000 to advance the understanding of CLCN4-related condition. We received a number of strong proposals, and while we...
by Rebeca Ridings Figueroa | Sep 4, 2023 | Research
Your Voice Matters: Join the study on Speech & Language in CLCN4-related condition We are thrilled to announce that the Translational Centre of Research Excellence for Speech Disorders (Australia) has launched an international study aimed at exploring speech and...
by Rebeca Ridings Figueroa | Aug 28, 2023 | Research
Pilot Grant Program 2023 – applications now closed Overview CLCN4-related neurodevelopmental condition (CLCN4-NDC) is one of the more recently discovered rare X-linked monogenic disorders. It is caused by inherited or de novo pathogenic variants of the CLCN4...
by Rebeca Ridings Figueroa | Mar 14, 2023 | Research
Clcn4 rat models – they are here! Thanks to the fundraising efforts of the CLCN4 community, who helped us raise £50,000 towards this project, and the fantastic work of the PHENOMIN-ICS team (France), two Clcn4 rat models are now available to...
Recent Comments